Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) alpha and beta.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 12547836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling*

  2001cited by this paper
• Immortalized testis cell lines from estrogen receptor (ER) alpha knock-out and wild-type mice expressing functional ERalpha or ERbeta.

  2001cited by this paper
• Mutations in the Estrogen Receptor Ligand Binding Domain Discriminate between Hormone-dependent Transactivation and Transrepression*

  2000cited by this paper
• Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.

  2000cited by this paper
• The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

  2000cited by this paper
• Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.

  2000cited by this paper
• Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

  1999cited by this paper
• Molecular Determinants of the Estrogen Receptor-Coactivator Interface

  1999cited by this paper
• Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

  1999cited by this paper
• Estrogen receptor null mice: what have we learned and where will they lead us?

  1999cited by this paper
• Estrogen receptor-beta: implications for the prostate gland.

  1999cited by this paper
• Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.

  1999cited by this paper
• The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.

  1999cited by this paper
• The Molecular Pharmacology of SERMs.

  1999cited by this paper
• Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.

  1998cited by this paper
• The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

  1998cited by this paper
• A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression.

  1998cited by this paper
• Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

  1998cited by this paper
• Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors.

  1998cited by this paper
• Cloning and characterization of human estrogen receptor beta isoforms.

  1998cited by this paper
• Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.

  1997cited by this paper
• Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

  1997cited by this paper
• Identification of a third autonomous activation domain within the human estrogen receptor.

  1997cited by this paper
• Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern.

  1997cited by this paper
• Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity.

  1996cited by this paper
• Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.

  1996cited by this paper
• Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.

  1996cited by this paper
• Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.

  1995cited by this paper
• Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.

  1993cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.

  1989cited by this paper
• Diethylstilbestrol metabolites and analogs. New probes for the study of hormone action.

  1979cited by this paper
• Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogs.

  1978cited by this paper
• Breast tumor cell lines from pleural effusions.

  1974cited by this paper

• The steroid hormone estriol (E3) regulates epigenetic programming of fetal mouse brain and reproductive tract

  2022cites this paper
• Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity.

  2021cites this paper
• In Vitro and Vivo Identification, Metabolism and Action of Xenoestrogens: An Overview

  2021cites this paper
• Endocrine disruptors of sex hormone activities.

  2021cites this paper
• Characterization of Estrogenic and Androgenic Activities for Bisphenol A-like Chemicals (BPs): In Vitro Estrogen and Androgen Receptors Transcriptional Activation, Gene Regulation, and Binding Profiles.

  2019cites this paper
• ERE‐dependent transcription and cell proliferation: Independency of these two processes mediated by the introduction of a sulfone function into the weak estrogen estrothiazine

  2017cites this paper
• Research resource: comparison of gene profiles from wild-type ERα and ERα hinge region mutants.

  2014cites this paper
• Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes

  2013cites this paper
• Consensus Computational Ligand‐Based Design for the Identification of Novel Modulators of Human Estrogen Receptor Alpha

  2012cites this paper
• Differential Estrogenic Actions of Endocrine-Disrupting Chemicals Bisphenol A, Bisphenol AF, and Zearalenone through Estrogen Receptor α and β in Vitro

  2012cites this paper
• Selective Mutations in Estrogen Receptor α D-domain Alters Nuclear Translocation and Non-estrogen Response Element Gene Regulatory Mechanisms*

  2011cites this paper
• Does the oestrogen receptor encourage oestrogenicity in environmental pollutants? The case of 4-nonylphenol

  2011cites this paper
• Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds.

  2009cites this paper
• Molecular structural characteristics of estrogen receptor modulators as determinants of estrogen receptor selectivity.

  2008cites this paper
• Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor alpha.

  2008cites this paper
• Xenoestrogens: mechanisms of action and some detection studies.

  2008cites this paper
• Enantioselective dehydroxylation of enterodiol and enterolactone precursors by human intestinal bacteria.

  2007cites this paper
• Comparative profiling of the gene expression for estrogen responsiveness in cultured human cell lines.

  2007cites this paper
• Coactivation of estrogen receptor alpha (ER alpha)/Sp1 by vitamin D receptor interacting protein 150 (DRIP150).

  2007cites this paper
• Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.

  2007cites this paper
• Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.

  2006cites this paper
• Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.

  2006cites this paper
• Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma.

  2005cites this paper
• 4-Hydroxytamoxifen Inhibits Proliferation of Multiple Myeloma Cells In vitro through Down-Regulation of c-Myc, Up-Regulation of p27Kip1, and Modulation of Bcl-2 Family Members

  2005cites this paper
• Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.

  2005cites this paper
• DASH: a novel analysis method for molecular dynamics simulation data. Analysis of ligands of PPAR-gamma.

  2005cites this paper
• Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.

  2005cites this paper
• Non-steroidal subtype selective estrogens.

  2005cites this paper
• Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.

  2004cites this paper
• Enantioselective recognition of mono-demethylated methoxychlor metabolites by the estrogen receptor.

  2004cites this paper
• Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.

  2004cites this paper
• Xenoestrogens: mechanisms of action and detection methods

  2004cites this paper
• Reproductive toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in male rats.

  2004cites this paper
• Principles of Molecular Oncology

  2000cites this paper